Aequus Pharmaceuticals Inc (AQS.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
May 31, 16:00
Aequus Pharmaceuticals Total Liabilities (Quarterly): 6.040M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.040M |
| December 31, 2023 | 5.380M |
| September 30, 2023 | 4.759M |
| December 31, 2022 | 3.072M |
| September 30, 2022 | 3.036M |
| June 30, 2022 | 2.452M |
| March 31, 2022 | 2.654M |
| December 31, 2021 | 2.559M |
| September 30, 2021 | 2.519M |
| June 30, 2021 | 2.408M |
| March 31, 2021 | 2.451M |
| December 31, 2020 | 2.561M |
| September 30, 2020 | 3.069M |
| June 30, 2020 | 2.751M |
| March 31, 2020 | 2.717M |
| December 31, 2019 | 2.550M |
| September 30, 2019 | 2.437M |
| June 30, 2019 | 2.328M |
| March 31, 2019 | 0.9353M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.3149M |
| September 30, 2018 | 0.5398M |
| June 30, 2018 | 0.5696M |
| March 31, 2018 | 0.3969M |
| December 31, 2017 | 0.3668M |
| September 30, 2017 | 0.5558M |
| June 30, 2017 | 0.8484M |
| March 31, 2017 | 0.6571M |
| December 31, 2016 | 0.7444M |
| September 30, 2016 | 0.7061M |
| June 30, 2016 | 1.084M |
| March 31, 2016 | 0.5707M |
| December 31, 2015 | 1.145M |
| September 30, 2015 | 0.9441M |
| June 30, 2015 | 0.4679M |
| March 31, 2015 | 0.3728M |
| December 31, 2014 | 0.7445M |
| September 30, 2014 | 0.3225M |
| December 31, 2013 | 0.0567M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.328M
Minimum
Jun 2019
6.040M
Maximum
Mar 2024
3.097M
Average
2.607M
Median
Total Liabilities (Quarterly) Benchmarks
| Biocure Technology Inc | 0.3992M |
| Core One Labs Inc | 1.759M |
| Nova Mentis Life Science Corp | 0.6549M |
| Nanosphere Health Sciences Inc | 2.088M |
| Lobe Sciences Ltd | 3.343M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.092M |
| Shareholders Equity (Quarterly) | -4.948M |
| Debt to Equity Ratio | -1.012 |
| Current Ratio | 0.0865 |
| Net Debt Paydown Yield | -44.88% |